Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,438 signal articles · 141 in last 24h · 154,019 total before filter · latest 26m ago
141last 24h
874last 7d
144● bullish (7d)
99● bearish (7d)
214publishers
AllMacro208Earnings106M&A125Regulatory22Product21Analyst16
✕ clear all filtersticker: AMGNsentiment: bearishSentiment:bullishneutralbearishshow all (incl. clickbait)
Amgen (AMGN) Recalls Put Its Valuation Story Back In Focus
Simply Wall St.78d agobearish
Amgen (AMGN) Recalls Put Its Valuation Story Back In Focus

Amgen (AMGN) has moved into focus after initiating voluntary nationwide recalls of certain Corlanor and Sensipar tablet lots due to foreign substances and CGMP deviations, prompting investors to reassess drug quality and compliance risks. See our latest analysis for Amgen. Against this recall backdrop, Amgen’s recent momentum has stayed intact, with a 30 day share price return of 5.30% and a year to date share price return of 12.35%. The 1 year total shareholder return of 27.66% and 3 year...